11 employees
A new generation of cancer immunotherapy promise to change the paradigm of cancer treatment.
2014
$5M
from 1 investors over 1 rounds
GO Therapeutics raised $5M on August 17, 2017
Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD